Decker T, Ruhnke M
Abteilung für Immunopathologie, Humboldt-Universität zu Berlin, DDR.
Zentralbl Allg Pathol. 1988;134(2):197-205.
A high rate of hepatitis B virus (HBV) antigen carriers among patients with hepatocellular carcinoma (HCC) has been recorded from areas of endemic HBV infections in Africa and Asia, but there are only rare and contradictory data for Europe. 12 specimens of resected liver tissue were immunohistologically investigated for hepatitis B surface antigen (HBsAg) as well as for hepatitis B core antigen (HBcAg). HBsAg was contained in non-tumorous liver tissue in 66 per cent of these cases. In two cases detection of HBcAg in the liver provided evidence to replication of the virus. HBcAg plus HBsAg were present in tumour tissue in one case. All of the HBV antigen carriers did not have chronic hepatitis. On the other hand, all patients with chronic hepatitis had HBV antigens in their liver tissue. HBV antigens were detectable in 7 non-cirrhotic livers, but were contained in only one of two cirrhotic livers. These results are likely to suggest a possible relevance of HBV infection to the aetiology of HCC even in central Europe without customary liver cirrhosis.
在非洲和亚洲乙肝病毒(HBV)感染流行地区,肝细胞癌(HCC)患者中HBV抗原携带者的比例较高,但欧洲的相关数据却很少且相互矛盾。对12份切除的肝组织标本进行免疫组织学检查,以检测乙肝表面抗原(HBsAg)和乙肝核心抗原(HBcAg)。在66%的病例中,非肿瘤性肝组织中含有HBsAg。有两例在肝脏中检测到HBcAg,证明病毒在复制。有一例肿瘤组织中同时存在HBcAg和HBsAg。所有HBV抗原携带者均无慢性肝炎。另一方面,所有慢性肝炎患者的肝组织中均有HBV抗原。在7例非肝硬化肝脏中可检测到HBV抗原,但在2例肝硬化肝脏中只有1例含有HBV抗原。这些结果可能表明,即使在没有习惯性肝硬化的中欧地区,HBV感染可能与HCC的病因有关。